BE832271A - Nouveaux steroides cardiotoniques, leur procede de preparation et leur utilisation therapeutique - Google Patents

Nouveaux steroides cardiotoniques, leur procede de preparation et leur utilisation therapeutique

Info

Publication number
BE832271A
BE832271A BE159066A BE159066A BE832271A BE 832271 A BE832271 A BE 832271A BE 159066 A BE159066 A BE 159066A BE 159066 A BE159066 A BE 159066A BE 832271 A BE832271 A BE 832271A
Authority
BE
Belgium
Prior art keywords
preparation process
therapeutic use
cardiotonic steroids
new
new cardiotonic
Prior art date
Application number
BE159066A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE832271A publication Critical patent/BE832271A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE159066A 1974-08-08 1975-08-08 Nouveaux steroides cardiotoniques, leur procede de preparation et leur utilisation therapeutique BE832271A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1085574A CH621803A5 (xx) 1974-08-08 1974-08-08

Publications (1)

Publication Number Publication Date
BE832271A true BE832271A (fr) 1975-12-01

Family

ID=4367535

Family Applications (1)

Application Number Title Priority Date Filing Date
BE159066A BE832271A (fr) 1974-08-08 1975-08-08 Nouveaux steroides cardiotoniques, leur procede de preparation et leur utilisation therapeutique

Country Status (12)

Country Link
US (1) US4000125A (xx)
JP (1) JPS5141372A (xx)
AR (1) AR217617A1 (xx)
BE (1) BE832271A (xx)
CA (1) CA1049499A (xx)
CH (1) CH621803A5 (xx)
DE (1) DE2534981A1 (xx)
DK (1) DK139101B (xx)
ES (1) ES440110A1 (xx)
FR (1) FR2281124A1 (xx)
GB (1) GB1484655A (xx)
SE (1) SE418401B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1144136B (it) * 1980-03-05 1986-10-29 Zenyaku Kogyo Kk Glucosidi di condurango agenti antitumorali che li comprendono e procedimento per la loro preparazione
US5373095A (en) * 1985-10-18 1994-12-13 The Upjohn Company Steroid compounds
IT1262931B (it) * 1992-01-16 1996-07-22 Zambon Spa Composti steroidei 17(piridazin-n-ossido)-sostituiti attivi sul sistema cardiovascolare
DE4227616C2 (de) * 1992-08-20 1995-04-13 Sigma Tau Ind Farmaceuti 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen
US20100047338A1 (en) * 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
PT1853619E (pt) * 2005-03-02 2011-01-03 Univ Maryland 3-beta-hidroxi-17-(1h-benzimidazol-1-il)androsta-5,16-dieno para utilização no tratamento de uma doença da próstata
US20110105445A1 (en) * 2008-03-12 2011-05-05 University Of Maryland, Baltimore Androgen receptor inactivation contributes to antitumor efficacy of cyp17 inhibitors in prostate cancer
GB2470700B (en) 2008-03-25 2012-08-08 Univ Maryland C-17 heteroaryl steroidal CYP17 inhibitors
WO2009129208A2 (en) * 2008-04-14 2009-10-22 University Of Maryland, Baltimore Compositions and methods of inducing endoplasmic reticulum stress reponse
AU2010210422A1 (en) 2009-02-05 2011-08-18 Tokai Pharmaceuticals, Inc. Novel prodrugs of steroidal CYP17 inhibitors/antiandrogens
GB2479693B (en) 2009-02-05 2014-04-09 Tokai Pharmaceuticals Inc Steroidal CYP17 inhibitors and their use in the treatment of cancer and prostate hyperplasia
CA2770092A1 (en) 2009-08-07 2011-02-10 Tokai Pharmaceuticals, Inc. Treatment of prostate cancer
CA2904170A1 (en) 2013-03-14 2014-09-25 University Of Maryland, Baltimore Androgen receptor down-regulating agents and uses thereof
WO2015023710A1 (en) 2013-08-12 2015-02-19 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
EP3313858B1 (en) * 2015-06-29 2019-09-25 Universiteit Gent Methods for the site-selective coupling of a first agent to a second agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838163A (en) * 1968-11-22 1974-09-24 Hoffmann La Roche Substituted isoxazole derivatives as steroid intermediates

Also Published As

Publication number Publication date
SE7508908L (sv) 1976-02-09
AR217617A1 (es) 1980-04-15
FR2281124A1 (fr) 1976-03-05
DE2534981A1 (de) 1976-02-19
JPS5141372A (xx) 1976-04-07
DK139101C (xx) 1979-05-21
CA1049499A (en) 1979-02-27
DK358875A (xx) 1976-02-09
GB1484655A (en) 1977-09-01
SE418401B (sv) 1981-05-25
FR2281124B1 (xx) 1980-05-16
US4000125A (en) 1976-12-28
ES440110A1 (es) 1977-02-16
CH621803A5 (xx) 1981-02-27
DK139101B (da) 1978-12-18

Similar Documents

Publication Publication Date Title
FR2286134A1 (fr) Nouvelles urethannoxazolidines, et leur procede de preparation
FR2293449A1 (fr) Polyurethannes anioniques, leur procede de preparation et leur utilisation
FR2285389A1 (fr) Nouveaux multiheteromacrocycles et leur procede de preparation
BE832271A (fr) Nouveaux steroides cardiotoniques, leur procede de preparation et leur utilisation therapeutique
LU76848A1 (fr) Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application therapeutique
BE827323A (fr) Nouvelles diaryl-1,1 oxadiazole-1 alkylamines, leur procede de preparation et leur utilisation therapeutique
FR2279709A1 (fr) Nouveaux bicyclooctadienes et leur procede de preparation
FR2280386A1 (fr) 7-methoxy-6-thia-tetracyclines et leur procede de preparation
BE834400A (fr) Nouveaux derives de pyridine, leur procede de preparation et leur utilisation
FR2323388A1 (fr) Nouveaux phenylpiperazinotetrahydronaphtols, leur preparation et leur utilisation therapeutique comme hypotenseurs
BE830814A (fr) N-alkyl-iminoalanes oligomeres et leur procede de preparation
BE835524A (fr) Derives thiazolyphtalides, leur procede de preparation et leur utilisation
BE832128A (fr) Derives antibiotiques de xk-62-2, leur procede de preparation et leur utilisation therapeutique
FR2313029A1 (fr) Fluoroprostaglandines, procede permettant leur preparation, et leur utilisation therapeutique
BE836400A (fr) Nouvelles combinaisons medicamenteuses et leur procede de preparation
BE838745A (fr) Nouveaux colorants disperses, leur procede de preparation et leur utilisation
BE835427A (fr) Nouveaux methylenesteroides, et leur procede de preparation
BE817351A (fr) Nouveaux steroides et leur procede de preparation
BE849571A (fr) Diurethannes, leur procede de preparation et leur utilisation
BE826139A (fr) 11beta-fluoro-androstenes et leur procede de preparation
FR2280383A1 (fr) Nouveaux 17a,21-diesters de 17a,21-dihydroxy steroides, leur procede de preparation, et leur application
BE824179A (fr) Bis-dihalogeno-s-triazinyl-urees et leur procede de preparation
FR2293937A1 (fr) Nouveaux steroides, leur procede de preparation et leurs applications
BE827712A (fr) Colorants azoiques leur procede de preparation et leur utilisation
BE834347A (fr) Nouveaux corticoides, leur procede de preparation et leur utilisation